Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics

Detalhes bibliográficos
Autor(a) principal: Dias, Lucinara Dadda
Data de Publicação: 2017
Outros Autores: Casali, Karina Rabello [UNIFESP], Ghem, Carine, da Silva, Melissa Kristocheck, Sausen, Grasiele, Palma, Patricia Bonini, Covas, Dimas Tadeu, Kalil, Renato A. K., Schaan, Beatriz D., Nardi, Nance Beyer, Markoski, Melissa Medeiros
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1186/s12967-017-1262-0
https://repositorio.unifesp.br/handle/11600/53434
Resumo: Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 +/- 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 +/- 1.5 x 10(7) cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.
id UFSP_94432ab3dcb0e9fe19f3db76a7f7ebcc
oai_identifier_str oai:repositorio.unifesp.br:11600/53434
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Dias, Lucinara DaddaCasali, Karina Rabello [UNIFESP]Ghem, Carineda Silva, Melissa KristocheckSausen, GrasielePalma, Patricia BoniniCovas, Dimas TadeuKalil, Renato A. K.Schaan, Beatriz D.Nardi, Nance BeyerMarkoski, Melissa Medeiros2020-06-26T16:30:14Z2020-06-26T16:30:14Z2017http://dx.doi.org/10.1186/s12967-017-1262-0Journal Of Translational Medicine. London, v. 15, p. -, 2017.1479-5876https://repositorio.unifesp.br/handle/11600/53434WOS000406324500001.pdf10.1186/s12967-017-1262-0WOS:000406324500001Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 +/- 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 +/- 1.5 x 10(7) cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.CNPq-Conselho Nacional de Desenvolvimento Cientifico e TecnologicoCAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Programa de Cooperacao Academico (Procad)FAPERGS-Fundacao de Amparo a Pesquisa do Estado do Rio Grande do SulFundacao Univ Cardiol, Inst Cardiol, Programa Posgrad Ciencias Saude Cardiol, Ave Princesa Isabel,370,3 Andar, BR-90620001 Porto Alegre, RS, BrazilUniv Fed Sao Paulo, Sao Jose Dos Campos, SP, BrazilHosp Clin Porto Alegre, Serv Patol Clin, Porto Alegre, RS, BrazilUniv Sao Paulo, Fac Med Ribeirao Preto, Lab Citometria Fluxo, Ctr Reg Hemoterapia,Hosp Clin, Sao Paulo, SP, BrazilUniv Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, BrazilUniv Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, BrazilUniv Luterana Brasil, Lab Celulas Tronco & Engn Tecidos, Canoas, RS, BrazilUniv Fed Sao Paulo, Sao Jose Dos Campos, SP, BrazilCNPqCAPESFAPERGSWeb of Science-engBiomed Central LtdJournal Of Translational MedicineMSC establishmentStem cells cultureCell therapyValvular heart diseaseIschemic heart diseaseMesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kineticsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleLondon15info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000406324500001.pdfapplication/pdf1709723${dspace.ui.url}/bitstream/11600/53434/1/WOS000406324500001.pdf62ae4804ebd8c9b8772ad056e183820eMD51open accessTEXTWOS000406324500001.pdf.txtWOS000406324500001.pdf.txtExtracted texttext/plain43300${dspace.ui.url}/bitstream/11600/53434/8/WOS000406324500001.pdf.txt9a2dab84655495711db5e3b6770b51a7MD58open accessTHUMBNAILWOS000406324500001.pdf.jpgWOS000406324500001.pdf.jpgIM Thumbnailimage/jpeg6931${dspace.ui.url}/bitstream/11600/53434/10/WOS000406324500001.pdf.jpg1d38122c2fd218b518f775d366997120MD510open access11600/534342023-06-05 19:09:18.763open accessoai:repositorio.unifesp.br:11600/53434Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-06-05T22:09:18Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
spellingShingle Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
Dias, Lucinara Dadda
MSC establishment
Stem cells culture
Cell therapy
Valvular heart disease
Ischemic heart disease
title_short Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_full Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_fullStr Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_full_unstemmed Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_sort Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
author Dias, Lucinara Dadda
author_facet Dias, Lucinara Dadda
Casali, Karina Rabello [UNIFESP]
Ghem, Carine
da Silva, Melissa Kristocheck
Sausen, Grasiele
Palma, Patricia Bonini
Covas, Dimas Tadeu
Kalil, Renato A. K.
Schaan, Beatriz D.
Nardi, Nance Beyer
Markoski, Melissa Medeiros
author_role author
author2 Casali, Karina Rabello [UNIFESP]
Ghem, Carine
da Silva, Melissa Kristocheck
Sausen, Grasiele
Palma, Patricia Bonini
Covas, Dimas Tadeu
Kalil, Renato A. K.
Schaan, Beatriz D.
Nardi, Nance Beyer
Markoski, Melissa Medeiros
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Dias, Lucinara Dadda
Casali, Karina Rabello [UNIFESP]
Ghem, Carine
da Silva, Melissa Kristocheck
Sausen, Grasiele
Palma, Patricia Bonini
Covas, Dimas Tadeu
Kalil, Renato A. K.
Schaan, Beatriz D.
Nardi, Nance Beyer
Markoski, Melissa Medeiros
dc.subject.eng.fl_str_mv MSC establishment
Stem cells culture
Cell therapy
Valvular heart disease
Ischemic heart disease
topic MSC establishment
Stem cells culture
Cell therapy
Valvular heart disease
Ischemic heart disease
description Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 +/- 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 +/- 1.5 x 10(7) cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.
publishDate 2017
dc.date.issued.fl_str_mv 2017
dc.date.accessioned.fl_str_mv 2020-06-26T16:30:14Z
dc.date.available.fl_str_mv 2020-06-26T16:30:14Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.].fl_str_mv http://dx.doi.org/10.1186/s12967-017-1262-0
dc.identifier.citation.fl_str_mv Journal Of Translational Medicine. London, v. 15, p. -, 2017.
dc.identifier.uri.fl_str_mv https://repositorio.unifesp.br/handle/11600/53434
dc.identifier.issn.none.fl_str_mv 1479-5876
dc.identifier.file.none.fl_str_mv WOS000406324500001.pdf
dc.identifier.doi.none.fl_str_mv 10.1186/s12967-017-1262-0
dc.identifier.wos.none.fl_str_mv WOS:000406324500001
url http://dx.doi.org/10.1186/s12967-017-1262-0
https://repositorio.unifesp.br/handle/11600/53434
identifier_str_mv Journal Of Translational Medicine. London, v. 15, p. -, 2017.
1479-5876
WOS000406324500001.pdf
10.1186/s12967-017-1262-0
WOS:000406324500001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Journal Of Translational Medicine
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
dc.coverage.none.fl_str_mv London
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/53434/1/WOS000406324500001.pdf
${dspace.ui.url}/bitstream/11600/53434/8/WOS000406324500001.pdf.txt
${dspace.ui.url}/bitstream/11600/53434/10/WOS000406324500001.pdf.jpg
bitstream.checksum.fl_str_mv 62ae4804ebd8c9b8772ad056e183820e
9a2dab84655495711db5e3b6770b51a7
1d38122c2fd218b518f775d366997120
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764237468073984